Penn spinout Linnaeus Therapeutics gets key FDA designation

The company is developing new cancer therapies based on the discoveries of a Penn researcher.

Source: bizjournals.com Health Care:Physician Practices headlines - March 12, 2021 Category: American Health Authors: John George Source Type: news